Health & Medicine
FDA Okays Chelsea's Blood Pressure Drug Northera
Chelsea Therapeutics' Northera capsule (droxidopa) is now approved for the treatment of neurogenic orthostatic hypotension (NOH), The U.S. Food and Drug Administration said Tuesday.
Latest Research Articles
Vitamin D Proves Relief for Chronic Hives
Drought Aided the Spread of Typhus
LGB Individuals Living in Anti-Gay Communities Die Younger
Hearty Appetite during Childhood Linked with Obesity
Brisk Walking Delays Cognitive Decline in Older Adults
Stress Hormone Cortisol Could Act as Biomarker for Depression, Researchers Say
Study of Ganges River Highlights Growing Antibacterial Resistance
Male Drinking Linked to Fetal Alcohol Syndrome
Loneliness can up Death Risk in Older Adults
Bullying Damages Physical, Mental Health of Victims
Grape Seed Shown Effective Against Bowel Cancer
Diet and Exercise in Pregnant Women Leads to Less Overweight Babies
MOST POPULAR
-
Weak Spot in Earth's Magnetic Field Raises Concerns for Humanity's Future
-
Spectacular Northern Lights Show Possible in 10 States as Geomagnetic Storm Approaches
-
Earth's Magnetic North Pole Shifts Toward Russia, Scientists Update Its Location
-
Mount Rainier's Volcanic Activity Closely Watched by Scientists
-
Undersea Volcano Off Oregon Coast Could Erupt in 2025 After Scientists Notice 'Swelling'
